沃森生物
(300142)
| 流通市值：217.05亿 | | | 总市值：222.46亿 |
| 流通股本：15.68亿 | | | 总股本：16.07亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 4,112,487,510.31 | 4,364,534,810.22 | 4,086,661,950.9 | 3,906,337,287 |
| 应收票据及应收账款 | 3,059,377,867.06 | 3,100,608,478.53 | 3,381,360,469.68 | 3,704,989,916.24 |
| 应收账款 | 3,059,377,867.06 | 3,100,608,478.53 | 3,381,360,469.68 | 3,704,989,916.24 |
| 预付款项 | 11,568,831.38 | 16,405,974.09 | 15,825,232.87 | 23,852,140.59 |
| 其他应收款合计 | 163,477,708.77 | 163,228,680.28 | 174,864,600.75 | 182,960,705.91 |
| 其中:应收利息 | - | - | 870,239.48 | 1,015,604.87 |
| 存货 | 1,100,930,116.64 | 1,034,636,972.12 | 1,089,470,643.65 | 1,142,036,872.62 |
| 其他流动资产 | 48,265,422.92 | 53,755,480.12 | 41,830,439.33 | 36,092,466.41 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 8,496,107,457.08 | 8,733,170,395.36 | 8,790,013,337.18 | 8,996,269,388.77 |
| 非流动资产: | | | | |
| 长期股权投资 | 15,189,333.71 | 15,102,493.64 | 14,282,645.32 | 14,316,385.71 |
| 其他权益工具投资 | 562,000,000 | 562,000,000 | 562,000,000 | 562,000,000 |
| 其他非流动金融资产 | 404,220,900 | 480,238,800 | 647,600,000 | 697,336,000 |
| 投资性房地产 | 27,393,259.9 | 25,955,026.79 | 39,959,236.78 | 40,636,281.99 |
| 固定资产 | 2,029,634,209.16 | 2,081,651,728.75 | 1,616,688,514.71 | 1,610,619,355.85 |
| 在建工程 | 1,917,761,302.54 | 1,645,415,658.14 | 1,894,581,531.24 | 1,744,823,057.28 |
| 使用权资产 | 39,321,198.85 | 41,282,947.52 | 40,628,686.82 | 48,708,295.9 |
| 无形资产 | 1,055,025,460.28 | 1,085,886,518.84 | 1,097,070,866.21 | 1,127,784,621.21 |
| 开发支出 | 410,895,540.63 | 399,656,860.37 | 373,402,627.92 | 333,302,600.85 |
| 商誉 | 33,657,636.81 | 33,657,636.81 | 33,657,636.81 | 33,657,636.81 |
| 长期待摊费用 | 69,228,393.59 | 73,818,477.61 | 37,390,619.83 | 40,796,912.47 |
| 递延所得税资产 | 100,178,268.87 | 103,443,601.79 | 116,142,846.74 | 112,425,465.18 |
| 其他非流动资产 | 226,268,915.16 | 307,589,127.78 | 327,735,396.47 | 287,658,033.95 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 6,890,774,419.5 | 6,855,698,878.04 | 6,801,140,608.85 | 6,654,064,647.2 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 15,386,881,876.58 | 15,588,869,273.4 | 15,591,153,946.03 | 15,650,334,035.97 |
| 流动负债: | | | | |
| 短期借款 | 320,270,722.22 | 320,270,722.22 | 100,088,888.89 | 130,007,111.11 |
| 应付票据及应付账款 | 1,906,806,679.61 | 1,805,081,377.84 | 1,888,443,890.86 | 2,053,424,730.94 |
| 其中：应付票据 | 33,124,587.2 | 32,654,333.23 | 12,950,455.49 | 18,273,589.94 |
| 应付账款 | 1,873,682,092.41 | 1,772,427,044.61 | 1,875,493,435.37 | 2,035,151,141 |
| 预收款项 | 3,963.31 | 963.31 | 32,956.63 | 64,949.92 |
| 合同负债 | 32,929,119.53 | 30,474,293.7 | 34,606,651.44 | 24,088,113.27 |
| 应付职工薪酬 | 26,903,399.66 | 116,575,723.97 | 25,001,478.69 | 30,504,118.32 |
| 应交税费 | 24,193,367.37 | 42,800,808 | 30,250,774.15 | 49,340,459.33 |
| 其他应付款合计 | 73,794,348.9 | 91,800,689.76 | 94,779,295.01 | 154,772,213.7 |
| 一年内到期的非流动负债 | 36,155,179.79 | 30,662,101.02 | 20,012,303.73 | 19,526,370.38 |
| 其他流动负债 | 556,625,788.18 | 766,240,055.64 | 838,868,542.61 | 802,262,420.58 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 2,977,682,568.57 | 3,203,906,735.46 | 3,032,084,782.01 | 3,263,990,487.55 |
| 非流动负债: | | | | |
| 长期借款 | 434,598,514.52 | 434,895,613.99 | 416,710,268.03 | 371,372,057.04 |
| 租赁负债 | 13,656,771.98 | 20,595,034.89 | 16,990,154.54 | 26,550,566.36 |
| 预计负债 | 43,634,633.12 | 42,075,669.63 | - | - |
| 递延收益 | 415,960,491.2 | 423,326,595.96 | 439,839,079.17 | 431,515,619.15 |
| 递延所得税负债 | 67,676,648.31 | 68,709,601.5 | 84,265,336.41 | 90,321,248.51 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 975,527,059.13 | 989,602,515.97 | 957,804,838.15 | 919,759,491.06 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 3,953,209,627.7 | 4,193,509,251.43 | 3,989,889,620.16 | 4,183,749,978.61 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,607,348,484 | 1,607,348,484 | 1,607,348,484 | 1,607,348,484 |
| 资本公积 | 4,899,514,142.72 | 4,899,514,142.72 | 4,967,867,312.95 | 4,967,867,312.95 |
| 减:库存股 | 358,629,573.18 | 358,629,573.18 | 358,629,573.18 | 358,629,573.18 |
| 其他综合收益 | 217,175,000 | 217,175,000 | 217,175,000 | 217,175,000 |
| 盈余公积 | 81,031,665.66 | 81,031,665.66 | 81,031,665.66 | 81,031,665.66 |
| 未分配利润 | 2,916,964,023.99 | 2,902,836,489.87 | 3,036,822,735.16 | 2,938,686,094.63 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 9,363,403,743.19 | 9,349,276,209.07 | 9,551,615,624.59 | 9,453,478,984.06 |
| 少数股东权益 | 2,070,268,505.69 | 2,046,083,812.9 | 2,049,648,701.28 | 2,013,105,073.3 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 11,433,672,248.88 | 11,395,360,021.97 | 11,601,264,325.87 | 11,466,584,057.36 |
| 负债和股东权益合计 | 15,386,881,876.58 | 15,588,869,273.4 | 15,591,153,946.03 | 15,650,334,035.97 |
| 公告日期 | 2024-04-25 | 2024-03-30 | 2023-10-26 | 2023-08-26 |
| 审计意见(境内) | | 标准无保留意见 | | |